What are the clinical benefits of recombinant gonadotrophins?

E-ISSN： 0268-1161|14|9|2189-2190

ISSN： 1460-2350

Source： Human Reproduction, Vol.14, Iss.9, 1999-09, pp. : 2189-2190

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

ESHRE. The clinical benefits of recombinant gonadotrophins

Human Reproduction, Vol. 15, Iss. 3, 2000-03 ,pp. : 734-735

Oxford University Press

Access to resources Recommend Favorite

Clinical efficacy of recombinant gonadotrophins

By Balen Adam H. Hayden Catherine J.

Human Reproduction, Vol. 14, Iss. 6, 1999-06 ,pp. : 1411-1417

Oxford University Press

Access to resources Recommend Favorite

Prion transmission in blood and urine: what are the implications for recombinant and urinary-derived gonadotrophins?

By Reichl H.

Human Reproduction, Vol. 17, Iss. 10, 2002-10 ,pp. : 2501-2508

Oxford University Press

Access to resources Recommend Favorite

Prions, urinary gonadotrophins and recombinant gonadotrophins

By Matorras Roberto Rodríguez‐Escudero Francisco Javier

Human Reproduction, Vol. 18, Iss. 5, 2003-05 ,pp. : 1129-1130

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients

By Jansen CAM

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 2995-2999

Oxford University Press

Access to resources Recommend Favorite